Northwest Biotherapeutics NWBO Stock
Northwest Biotherapeutics Price Chart
Northwest Biotherapeutics NWBO Financial and Trading Overview
| Northwest Biotherapeutics stock price | 0.18 USD |
| Previous Close | 0.17 USD |
| Open | 0.17 USD |
| Bid | 0.17 USD x 3000000 |
| Ask | 0.17 USD x 1841400 |
| Day's Range | 0.17 - 0.18 USD |
| 52 Week Range | 0.14 - 0.37 USD |
| Volume | 2.3M USD |
| Avg. Volume | 3.1M USD |
| Market Cap | 289.96M USD |
| Beta (5Y Monthly) | -0.62 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.02 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 1 USD |
NWBO Valuation Measures
| Enterprise Value | 360.43M USD |
| Trailing P/E | N/A |
| Forward P/E | -2.4285715 |
| PEG Ratio (5 yr expected) | 1.72 |
| Price/Sales (ttm) | 133.43694 |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | 165.869 |
| Enterprise Value/EBITDA | -7.571 |
Trading Information
Northwest Biotherapeutics Stock Price History
| Beta (5Y Monthly) | -0.62 |
| 52-Week Change | -29.16% |
| S&P500 52-Week Change | 18.35% |
| 52 Week High | 0.37 USD |
| 52 Week Low | 0.14 USD |
| 50-Day Moving Average | 0.18 USD |
| 200-Day Moving Average | 0.22 USD |
NWBO Share Statistics
| Avg. Volume (3 month) | 3.1M USD |
| Avg. Daily Volume (10-Days) | 2.73M USD |
| Shares Outstanding | 1.71B |
| Float | 1.67B |
| Short Ratio | 13.54 |
| % Held by Insiders | 4.10% |
| % Held by Institutions | 0.16% |
| Shares Short | 14.14M |
| Short % of Float | 15.08% |
| Short % of Shares Outstanding | 11.34% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:16 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | June 30, 2026 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -1438.042% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -59.63% |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | 2.17M USD |
| Revenue Per Share (ttm) | 0.001 USD |
| Quarterly Revenue Growth (yoy) | 516.00% |
| Gross Profit (ttm) | -21394000 USD |
| EBITDA | -47605000 USD |
| Net Income Avi to Common (ttm) | -38883000 USD |
| Diluted EPS (ttm) | -0.02 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 595K USD |
| Total Cash Per Share (mrq) | 0 USD |
| Total Debt (mrq) | 56.44M USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 0.035 |
| Book Value Per Share (mrq) | -0.038 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -48335000 USD |
| Levered Free Cash Flow (ttm) | -35601376 USD |
Profile of Northwest Biotherapeutics
| Country | United States |
| State | MD |
| City | Bethesda |
| Address | 4800 Montgomery Lane |
| ZIP | 20814 |
| Phone | 240 497 9024 |
| Website | https://www.nwbio.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 105 |
Northwest Biotherapeutics, Inc., a biotechnology company, engages in the development of personalized immune therapies for cancer. The company develops DCVax, a platform technology which uses activated dendritic cells to mobilize a patient's own immune system to attack cancer. It also engages in the development of its lead product candidate DCVax-L in Phase III trials for glioblastoma multiforme brain cancer. In addition, the company develops DCVax-Direct in Phase I trials to treat inoperable solid tumors. Northwest Biotherapeutics, Inc. was founded in 1996 and is headquartered in Bethesda, Maryland.
Q&A For Northwest Biotherapeutics Stock
What is a current NWBO stock price?
Northwest Biotherapeutics NWBO stock price today per share is 0.18 USD.
How to purchase Northwest Biotherapeutics stock?
You can buy NWBO shares on the OTC Markets OTCQB exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Northwest Biotherapeutics?
The stock symbol or ticker of Northwest Biotherapeutics is NWBO.
Which industry does the Northwest Biotherapeutics company belong to?
The Northwest Biotherapeutics industry is Biotechnology.
How many shares does Northwest Biotherapeutics have in circulation?
The max supply of Northwest Biotherapeutics shares is 1.71B.
What is Northwest Biotherapeutics Price to Earnings Ratio (PE Ratio)?
Northwest Biotherapeutics PE Ratio is now.
What was Northwest Biotherapeutics earnings per share over the trailing 12 months (TTM)?
Northwest Biotherapeutics EPS is -0.02 USD over the trailing 12 months.
Which sector does the Northwest Biotherapeutics company belong to?
The Northwest Biotherapeutics sector is Healthcare.
Northwest Biotherapeutics NWBO included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
|
|
{{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
US Tech Composite Total Return
XCMP
US
|
32881.64 USD — |
+0.37
|
— — | 32622.68 USD — | 32885.35 USD — | — - | — — |
- {{ link.label }} {{link}}
